# ZNF668

## Overview
ZNF668 is a gene that encodes the zinc finger protein 668, a member of the Kruppel C2H2-type zinc-finger protein family. This protein is characterized by its 16 C2H2-type zinc finger domains, which are primarily involved in DNA binding and transcriptional regulation (Okuno2023Relationship; Hu2011ZNF668). Zinc finger protein 668 plays a crucial role in maintaining genomic stability by participating in the DNA damage response (DDR) pathway, facilitating the repair of double-strand breaks, and regulating the stability of the tumor suppressor protein p53 (Hu2013Zinc; Hu2011ZNF668). The protein's interactions with other proteins, such as MDM2 and Tip60, underscore its function in tumor suppression and DNA repair mechanisms (Hu2013Zinc; Hu2011ZNF668). Mutations and altered expression of ZNF668 have been implicated in various cancers, including breast and non-small cell lung cancer, highlighting its clinical significance as a potential target for therapeutic interventions (Zhang2018Zinc; Hu2011ZNF668).

## Structure
ZNF668 is a Kruppel C2H2-type zinc-finger protein characterized by 16 C2H2-type zinc finger domains, which are typically involved in DNA binding (Okuno2023Relationship; Hu2011ZNF668). These zinc finger domains suggest a role in transcription regulation, particularly in association with RNA polymerase II (Okuno2023Relationship). The primary structure of ZNF668 includes specific amino acid regions crucial for its interactions with other proteins, such as MDM2 and p53, with identified regions between amino acids 84 to 190 and 268 to 367 being essential for these interactions (Hu2011ZNF668).

The tertiary structure of ZNF668, while not detailed in the context, is predicted by AlphaFold, indicating a complex folding necessary for its function in DNA binding and protein interactions (Okuno2023Relationship). ZNF668 is known to interact with nucleolar proteins like nucleostemin and nucleophosmin (NPM), suggesting a role in nucleolar processes and possibly indicating a quaternary structure involving these interactions (Hu2011ZNF668).

Post-translational modifications of ZNF668 include its involvement in the acetylation of histone H2AX, facilitated by its interaction with the Tip60 histone acetyltransferase, which is crucial for DNA damage response and repair (Hu2013Zinc).

## Function
ZNF668, a zinc finger protein, plays a crucial role in maintaining genomic stability in healthy human cells by participating in the DNA damage response (DDR) pathway. It is involved in the repair of double-strand breaks (DSBs) and cell survival following DNA damage, such as that caused by ionizing radiation (IR) or UV exposure. ZNF668 facilitates chromatin relaxation, which is essential for the recruitment of DNA repair proteins to damage sites. This process involves the interaction between ZNF668 and the histone acetyltransferase Tip60, leading to the acetylation of histone H2AX, a modification necessary for effective homologous recombination (HR) repair of DSBs (Hu2013Zinc).

ZNF668 also plays a role in the phosphorylation and recruitment of replication protein A (RPA) to DNA damage foci, which is critical for the ATR/Chk1 signaling pathway in response to UV damage (Hu2013Zinc). In addition to its role in DNA repair, ZNF668 is involved in regulating the stability and activity of the p53 protein, a key tumor suppressor. It stabilizes p53 by interfering with its degradation mediated by MDM2, thereby contributing to cell cycle regulation and apoptosis (Hu2011ZNF668).

## Clinical Significance
Mutations and altered expression of the ZNF668 gene have been implicated in various diseases, particularly cancer. In breast cancer, ZNF668 is frequently mutated, with mutations found in a significant portion of analyzed samples. These mutations impair the gene's ability to stabilize and activate the p53 protein, a crucial tumor suppressor, potentially contributing to cancer development (Hu2011ZNF668). ZNF668 also plays a role in DNA damage response and repair. Deficiency in ZNF668 leads to impaired DNA repair mechanisms, which can influence cancer progression and treatment responses (Hu2013Zinc).

In non-small cell lung cancer (NSCLC), decreased expression of ZNF668 is associated with advanced tumor stages and lymph node metastasis. Restoration of ZNF668 expression reduces cancer cell invasion and migration, suggesting its role as a tumor suppressor by modulating proteins involved in cell adhesion (Zhang2018Zinc).

ZNF668 mutations are also linked to a Mendelian disorder characterized by DNA damage repair deficiencies, leading to developmental delays and other phenotypic abnormalities. This disorder, proposed to be named ZNF668-related ZMAND, highlights the gene's critical role in maintaining genomic stability (Alsaif2021ZNF668).

## Interactions
ZNF668, a zinc finger protein, is involved in several critical protein interactions that contribute to its function as a tumor suppressor and its role in DNA damage response. ZNF668 interacts with the tumor suppressor protein p53 and its negative regulator MDM2. This interaction is crucial for regulating the stability and activity of p53, as ZNF668 can disrupt MDM2-mediated ubiquitination and degradation of p53, thereby stabilizing it (Hu2011ZNF668). ZNF668 also facilitates MDM2 autoubiquitination, which may alter MDM2's E3 ligase activity or its binding affinity for substrates (Hu2011ZNF668).

In the context of DNA damage response, ZNF668 interacts with Tip60, a histone acetyltransferase, to promote the acetylation of H2AX, a histone variant, following DNA damage. This acetylation is essential for chromatin relaxation and the recruitment of DNA repair proteins, facilitating homologous recombination repair (Hu2013Zinc). ZNF668 is also involved in the recruitment of RAD51 to DNA damage sites, which is crucial for effective DNA repair (Alsaif2021ZNF668). These interactions highlight ZNF668's role in maintaining genomic stability and its potential as a tumor suppressor.


## References


[1. (Alsaif2021ZNF668) Hessa S. Alsaif, Hatoon Al Ali, Eissa Faqeih, Sahar M. Ramadan, Magalie Barth, Estelle Colin, Clément Prouteau, Dominique Bonneau, Alban Ziegler, and Fowzan S. Alkuraya. Znf668 deficiency causes a recognizable disorder of dna damage repair. Human Genetics, 140(9):1395–1401, July 2021. URL: http://dx.doi.org/10.1007/s00439-021-02321-z, doi:10.1007/s00439-021-02321-z. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-021-02321-z)

[2. (Okuno2023Relationship) Yumiko Okuno, Mami Hattori-Kato, Hiroki Tanaka, Akiko Tonooka, and Takumi Takeuchi. Relationship between the reduced expression of zinc finger protein 668 in bladder cancer and its invasiveness. International Journal of Molecular Sciences, 24(10):8668, May 2023. URL: http://dx.doi.org/10.3390/ijms24108668, doi:10.3390/ijms24108668. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24108668)

[3. (Hu2011ZNF668) Ruozhen Hu, Guang Peng, Hui Dai, Eun-Kyoung Breuer, Katherine Stemke-Hale, Kaiyi Li, Ana M. Gonzalez-Angulo, Gordon B. Mills, and Shiaw-Yih Lin. Znf668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer. Cancer Research, 71(20):6524–6534, October 2011. URL: http://dx.doi.org/10.1158/0008-5472.can-11-0853, doi:10.1158/0008-5472.can-11-0853. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-11-0853)

[4. (Hu2013Zinc) Ruozhen Hu, Edward Wang, Guang Peng, Hui Dai, and Shiaw-Yih Lin. Zinc finger protein 668 interacts with tip60 to promote h2ax acetylation after dna damage. Cell Cycle, 12(13):2033–2041, July 2013. URL: http://dx.doi.org/10.4161/cc.25064, doi:10.4161/cc.25064. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.25064)

[5. (Zhang2018Zinc) Xiupeng Zhang, Guiyang Jiang, Jingjing Wu, Haijing Zhou, Yong Zhang, Yuan Miao, Yangyang Feng, and Juanhan Yu. Zinc finger protein 668 suppresses non-small cell lung cancer invasion and migration by downregulating snail and upregulating e-cadherin and zonula occludens-1. Oncology Letters, January 2018. URL: http://dx.doi.org/10.3892/ol.2018.7802, doi:10.3892/ol.2018.7802. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2018.7802)